Dysregulated serum response factor triggers formation of hepatocellular carcinoma.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Lipka, Daniel B
Authenrieth, Stella E
MetadataShow full item record
AbstractThe ubiquitously expressed transcriptional regulator serum response factor (SRF) is controlled by both Ras/MAPK (mitogen-activated protein kinase) and Rho/actin signaling pathways, which are frequently activated in hepatocellular carcinoma (HCC). We generated SRF-VP16(iHep) mice, which conditionally express constitutively active SRF-VP16 in hepatocytes, thereby controlling subsets of both Ras/MAPK- and Rho/actin-stimulated target genes. All SRF-VP16(iHep) mice develop hyperproliferative liver nodules that progresses to lethal HCC. Some murine (m)HCCs acquire Ctnnb1 mutations equivalent to those in human (h)HCC. The resulting transcript signatures mirror those of a distinct subgroup of hHCCs, with shared activation of oncofetal genes including Igf2, correlating with CpG hypomethylation at the imprinted Igf2/H19 locus.
CitationDysregulated serum response factor triggers formation of hepatocellular carcinoma. 2015, 61 (3):979-89 Hepatology
AffiliationHelmholtz Centre for infection research, Inhoffenstr. 7., 38124 Braunschweig, Germany.
JournalHepatology (Baltimore, Md.)
The following license files are associated with this item:
- Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells.
- Authors: Schratt G, Philippar U, Berger J, Schwarz H, Heidenreich O, Nordheim A
- Issue date: 2002 Feb 18
- Degeneration of the mouse retina upon dysregulated activity of serum response factor.
- Authors: Sandström J, Heiduschka P, Beck SC, Philippar U, Seeliger MW, Schraermeyer U, Nordheim A
- Issue date: 2011 Apr 29
- Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
- Authors: Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM
- Issue date: 2015 May 28
- Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
- Authors: Liu P, Terradillos O, Renard CA, Feldmann G, Buendia MA, Bernuau D
- Issue date: 1997 Apr
- Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
- Authors: Tang S, Hu W, Hu J, Wu S, Li J, Luo Y, Cao M, Zhou H, Jiang X
- Issue date: 2015 Feb